Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: A randomized trial

This publication has 11 references indexed in Scilit:

• 289 Multicenter Double-Blind Prospective Random Trial of Ceftizoxime vs. Placebo in Women with Preterm Premature Ruptured Membranes (Pprom)
  American Journal of Obstetrics and Gynecology, 1993
• A multicenter study of preterm birth weight and gestational age—specific neonatal mortality
  American Journal of Obstetrics and Gynecology, 1993
• Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986
  American Journal of Obstetrics and Gynecology, 1992
• Erythromycin therapy in preterm premature rupture of the membranes: A prospective, randomized trial of 220 patients
  American Journal of Obstetrics and Gynecology, 1992
• Antimicrobial therapy in preterm premature rupture of membranes: Results of a prospective, double-blind, placebo -controlled trial of erythromycin
  American Journal of Obstetrics and Gynecology, 1991
• Antibiotic therapy in preterm premature rupture of membranes: A randomized, prospective, double-blind trial
  American Journal of Obstetrics and Gynecology, 1990
• Ampicillin prophylaxis in preterm premature rupture of the membranes: A prospective randomized study
  American Journal of Obstetrics and Gynecology, 1988
• The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes
  American Journal of Obstetrics and Gynecology, 1988
• Management of preterm premature rupture of membranes: a Lack of a national consensus
  American Journal of Obstetrics and Gynecology, 1987
• Expectant Management of Rupture of Membranes at Term
  Southern Medical Journal, 1986